Dr. Vadim Jucaud's laboratory astatine nan Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) level that recapitulates cardinal structural, functional, and immunological features of quality liver tissue, enabling nan study of liver regeneration and immune-mediated allograft rejection successful a physiologically applicable quality system.
Liver transplantation remains nan superior therapeutic action for patients pinch end-stage liver disease, yet advancement successful knowing transplant rejection and insubstantial regeneration has been constricted by nan deficiency of experimental models that accurately bespeak quality liver architecture and immune interactions. Conventional civilization systems neglect to seizure nan multicellular organization, vascular complexity, and move immune responses that govern transplant outcomes, limiting their relevance for translational research.
To reside these limitations, researchers successful Dr. Vadim Jucaud's laboratory (VJLabs) engineered a vascularized liver tissueoid composed of donor-matched quality hepatic progenitor cells and intrahepatic portal vein endothelial cells. Within nan first week of move perfusion culture, nan tissueoid self-assembled into a perfusable microvascular network, followed by progressive maturation into a functional liver-like tissueoid complete a 49-day civilization period.
Using this platform, nan investigation squad demonstrated sustained insubstantial viability, preserved vascular integrity, and progressive hepatic function, including nan secretion of albumin, urea, complement factors, and hepatocyte maturation factor. The mature liver tissueoid contained aggregate liver-relevant compartment populations, including hepatocytes, cholangiocytes, Kupffer cells, stellate cells, and endothelial cells, intimately reflecting nan cellular diverseness of autochthonal quality liver tissue.
The LToC level was further tested to exemplary immune-mediated allograft rejection by perfusing nan mature tissueoid pinch allogeneic T cells. This vulnerability induced hallmark features of cellular rejection, including reduced insubstantial viability, endothelial disruption, nonaccomplishment of hepatic markers, accrued HLA-I expression, and a pronounced pro-inflammatory cytokine response. Elevated levels of IL-6, TNF-α, IL-1β, IFN-γ, granzyme A and B, and perforin mirrored immune activation patterns observed during objective transplant rejection.
This liver tissueoid-on-a-chip enables america to recreate cardinal aspects of liver regeneration and immune-mediated rejection wrong a human-relevant, vascularized insubstantial architecture."
Dr. Abdul Rahim Chethikkattuveli Salih, first writer of nan publication
"By integrating functional vasculature, aggregate liver compartment types, and immune responsiveness into a azygous platform, this strategy allows america to study transplant biology successful a much physiologically meaningful way," added Dr. Vadim Jucaud, Principal Investigator and Assistant Professor astatine nan Terasaki Institute. "This attack has nan imaginable to support immunosuppressive supplier information and beforehand much personalized strategies for liver transplantation."
This activity contributes to nan bequest of Dr. Paul I. Terasaki successful organ transplantation research, pinch nan overarching extremity of improving nan value of life for transplant patients.
"Dr. Terasaki believed that meaningful invention successful transplantation must ever beryllium driven by its imaginable to amended patients' lives," said Dr. Jucaud. "As 1 of nan past doctoral scholars trained by Dr. Paul I. Terasaki, carrying guardant his vision, done innovative, translational subject that bridges engineering, immunology, and transplantation, holds heavy individual value to me."
This committedness continues astatine nan Terasaki Institute, wherever advancing patient-centered, translational technologies remains a guiding rule and a tribute to Dr. Terasaki's lasting effect connected nan field.
Source:
Journal reference:
Salih, A. R. C., et al. (2026). Liver Tissueoid on‐a‐Chip Modeling Liver Regeneration and Allograft Rejection. Advanced Materials. DOI: 10.1002/adma.202521178. https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202521178
English (US) ·
Indonesian (ID) ·